Contraception Clinical Trial
Official title:
Evaluation of Values Clarification and Attitude Transformation Workshops on Abortion and Family Planning Service Provision and Client Experience in Socially Franchised Facilities in Ethiopia: A Cluster Randomized Study
Verified date | August 2021 |
Source | Ibis Reproductive Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Stigma around abortion and other reproductive health care is pervasive in most contexts and has been documented to have implications for the quality of care. This study aims to assess how Values Clarification and Attitude Transformation (VCAT) workshops for providers of abortion and family planning services influences service provision of abortion and family planning services, including the quality and person-centeredness of care provided. A secondary aim is to measure how provider attitudes, knowledge, and behavioral intent change over time as a result of the VCAT workshop.This study will be conducted across multiple regions in Ethiopia.
Status | Completed |
Enrollment | 217 |
Est. completion date | January 26, 2021 |
Est. primary completion date | January 26, 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | N/A and older |
Eligibility | Eligibility Criteria for clients: - Be willing to participate - Speak a language that is spoken by a study staff member - Be able to give informed consent - Have obtained abortion services (any age) or family planning services (<20 years old) from one of the participating social franchise facilities during one of the study periods Eligibility Criteria for providers: - Be trained to provide medication abortion and/or surgical abortion or be a community-based promoter employed by participating Blue Star facilities - Speak one of the study languages, including English, Amharic, Oromiffa, and Tigrinya. - Be willing to be randomized to either participate in VCAT training or be in the control arm. - Be willing to participate in the study - Be able to provide informed consent - Have a private space in the clinic for clients to complete the client survey and in-depth interview - Not have participated in 2018 pilot VCAT trainings - Work at a facility that has been a part of the social franchise network for at least six months prior to the study Eligibility criteria for promoters - Speak a language spoken by a study staff member - Be willing to participate in the study - Be willing to be randomized to participate in the VCAT training for community-based promoters |
Country | Name | City | State |
---|---|---|---|
Ethiopia | Blue Star facilities | Multiple | Addis Ababa, Oromiya, Tigray, Snnpr, Amhara |
Lead Sponsor | Collaborator |
---|---|
Ibis Reproductive Health | Marie Stopes Ethiopia, Marie Stopes International |
Ethiopia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Person-centered abortion and family planning scale | A validated scale measuring the dimensions of respectful and supportive care, communication and autonomy, and structural quality. The score is on a scale from 0 to 69 and higher scores represent more person-centered care. | 1.5 months | |
Primary | Percent of clients reporting essential person-centered care components | Percent of clients reporting having received kind and compassionate care from their provider, not feeling like they were treated differently based on age, marital status, or other characteristic, not feeling judged by their provider, having received respectful care, and feeling involved in the decisions around their care | 1.5 months | |
Secondary | Percent of providers that agree they could support a woman having an abortion or using family planning if they didn't agree with their decision | Agreement with the following four measures that capture agreement with providing abortion and family planning even in cases where providers may have conflicted values: I feel comfortable performing a safe abortion procedure for anyone who requests it regardless of the reason,I support a client's decision to have a safe abortion even if I didn't agree with her decision, I could provide family planning to a client even if I thought they were too young to be using contraception, I feel comfortable removing IUDs or implants even if I think the client shouldn't have it removed | 6 months | |
Secondary | Level of knowledge around interpretation for legal grounds for abortion in Ethiopia | Proportion knowing the legal indications for abortion in Ethiopia, the legal grounds for denial of abortion services, and the correct interpretation of the law around abortion services for married women, minors, women seeking services under the rape and incest clause, and women requesting an abortion under the grounds that the pregnancy is a risk to their health | 6 months | |
Secondary | Volume of patients | Volume of abortion and family planning clients under age 20 | 1 year | |
Secondary | Patient referrals by promoters | Number of referrals for safe abortion care and for family planning among clients under the age of 20 | 1 year | |
Secondary | Percent of providers who believe that women should have access to safe, comprehensive abortion care regardless of COVID-19 in Ethiopia | 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |